Vis-Rx Prime
Payments companies reported to CMS as associated with Vis-Rx Prime. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vis-Rx Prime, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vis-Rx Prime
These are the largest totals companies reported as associated with Vis-Rx Prime. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hiram Bezerra | Tampa, FL | Cardiovascular Disease | $60,000.00 |
| Donald Quimby | Tampa, FL | Interventional Cardiology | $13,229.29 |
| Timothy Henry | Cincinnati, OH | Interventional Cardiology | $5,686.39 |
| Eric Osborn | Boston, MA | Interventional Cardiology | $3,055.48 |
| Bernardo Cortese | Cleveland, OH | Interventional Cardiology | $3,000.00 |
| Evan Shlofmitz | Roslyn, NY | Interventional Cardiology | $2,282.42 |
| Morton Kern | Orange, CA | Cardiovascular Disease | $1,825.02 |
| Nadia Sutton | Nashville, TN | Interventional Cardiology | $1,200.00 |
| Aditya Sharma | Carlisle, PA | Interventional Cardiology | $248.10 |
| Alok Sharma | Minneapolis, MN | Interventional Cardiology | $190.09 |
Prescribed Vis-Rx Prime?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.